Capital International Investors Legend Biotech Corp Transaction History
Capital International Investors
- $475 Billion
- Q2 2024
A detailed history of Capital International Investors transactions in Legend Biotech Corp stock. As of the latest transaction made, Capital International Investors holds 2,162,711 shares of LEGN stock, worth $101 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,162,711
Previous 2,181,074
0.84%
Holding current value
$101 Million
Previous $122 Million
21.7%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding LEGN
# of Institutions
198Shares Held
74.2MCall Options Held
374KPut Options Held
387K-
Price T Rowe Associates Inc Baltimore, MD11.5MShares$538 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.51MShares$352 Million5.01% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.64MShares$311 Million7.6% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$268 Million0.01% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.77MShares$224 Million1.06% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $7.84B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...